Anti-TNF treatment in secondary amyloidosis.
Ortiz-Santamaria
V
V
Valls-Roc
M
M
Sanmartí
M
M
Olive
A
A
D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D013167:Spondylitis, Ankylosing / Q000150:complications*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab